Hypnosis for pain and anxiety management in cognitively impaired older adults undergoing scheduled lumbar punctures: a randomized controlled pilot study.
Anxiety
Hypnosis
Lumbar puncture
Older adults
Pain
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
02 09 2022
02 09 2022
Historique:
received:
14
01
2022
accepted:
26
07
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
Core cerebrospinal fluid (CSF) amyloid and tau biomarker assessment has been recommended to refine the diagnostic accuracy of Alzheimer's disease. Lumbar punctures (LP) are invasive procedures that might induce anxiety and pain. The use of non-pharmacological techniques must be considered to reduce the patient's discomfort, in this setting. The objective of this study was to examine the efficacy of hypnosis on anxiety and pain associated with LP. A monocentric interventional randomized-controlled pilot study is conducted in a university geriatric day hospital. Cognitively impaired patients aged over 70 were referred for scheduled LP for the diagnostic purpose (CSF biomarkers). The participants were randomly assigned either to a hypnosis intervention group or usual care. Pain and anxiety were both self-assessed by the patient and hetero-evaluated by the operator. We included 50 cognitively impaired elderly outpatients (women 54%, mean age 77.2 ± 5.0, mean Mini-Mental State Examination score 23.2 ± 3.5). Hypnosis was significantly associated with reduced self-assessed (p < 0.05) and hetero-assessed anxiety (p < 0.01). Hetero-evaluated pain was significantly lower in the hypnosis group (p < 0.05). The overall perception of hypnosis was safe, well-accepted, and feasible in all the participants of the intervention group with 68% perceiving the procedure as better or much better than expected. This pilot study suggested that hypnosis was feasible and may be used to reduce the symptoms of discomfort due to invasive procedures in older cognitively impaired patients. Our results also confirmed the overall good acceptance of LP in this population, despite the usual negative perception. ClinicalTrials.gov NCT04368572. Registered on April 30, 2020.
Sections du résumé
BACKGROUND
Core cerebrospinal fluid (CSF) amyloid and tau biomarker assessment has been recommended to refine the diagnostic accuracy of Alzheimer's disease. Lumbar punctures (LP) are invasive procedures that might induce anxiety and pain. The use of non-pharmacological techniques must be considered to reduce the patient's discomfort, in this setting. The objective of this study was to examine the efficacy of hypnosis on anxiety and pain associated with LP.
METHODS
A monocentric interventional randomized-controlled pilot study is conducted in a university geriatric day hospital. Cognitively impaired patients aged over 70 were referred for scheduled LP for the diagnostic purpose (CSF biomarkers). The participants were randomly assigned either to a hypnosis intervention group or usual care. Pain and anxiety were both self-assessed by the patient and hetero-evaluated by the operator.
RESULTS
We included 50 cognitively impaired elderly outpatients (women 54%, mean age 77.2 ± 5.0, mean Mini-Mental State Examination score 23.2 ± 3.5). Hypnosis was significantly associated with reduced self-assessed (p < 0.05) and hetero-assessed anxiety (p < 0.01). Hetero-evaluated pain was significantly lower in the hypnosis group (p < 0.05). The overall perception of hypnosis was safe, well-accepted, and feasible in all the participants of the intervention group with 68% perceiving the procedure as better or much better than expected.
CONCLUSIONS
This pilot study suggested that hypnosis was feasible and may be used to reduce the symptoms of discomfort due to invasive procedures in older cognitively impaired patients. Our results also confirmed the overall good acceptance of LP in this population, despite the usual negative perception.
TRIAL REGISTRATION
ClinicalTrials.gov NCT04368572. Registered on April 30, 2020.
Identifiants
pubmed: 36056417
doi: 10.1186/s13195-022-01065-w
pii: 10.1186/s13195-022-01065-w
pmc: PMC9438329
doi:
Banques de données
ClinicalTrials.gov
['NCT04368572']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
120Informations de copyright
© 2022. The Author(s).
Références
Int J Clin Exp Hypn. 2019 Jul-Sep;67(3):336-363
pubmed: 31251710
Int J Clin Exp Hypn. 2015;63(1):1-9
pubmed: 25365125
Psychiatry Res. 1992 Mar;41(3):237-48
pubmed: 1594710
BMC Geriatr. 2016 Jan 15;16:14
pubmed: 26767506
Eur J Pain. 2016 Aug;20(7):1185-93
pubmed: 26914411
Neurosci Biobehav Rev. 2019 Apr;99:298-310
pubmed: 30790634
Neuroimage. 2009 Sep;47(3):1047-54
pubmed: 19460446
Am J Clin Hypn. 2018 Jul;61(1):57-69
pubmed: 29771217
Am J Clin Hypn. 2015 Jan;57(3):314-29
pubmed: 25928681
Lancet. 2016 Jul 30;388(10043):505-17
pubmed: 26921134
Lancet. 2018 Mar 24;391(10126):1197-1204
pubmed: 29223694
Curr Alzheimer Res. 2009 Jun;6(3):290-2
pubmed: 19519311
Am J Clin Hypn. 2018 Oct;61(2):125-139
pubmed: 30260303
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Alzheimers Dis. 2017;56(2):519-527
pubmed: 27935555
Int J Clin Exp Hypn. 2001 Jan;49(1):56-67
pubmed: 11190793
Eur J Pain. 2002;6(1):1-16
pubmed: 11888223
Dtsch Arztebl Int. 2016 Apr 29;113(17):289-96
pubmed: 27173407
Psychosom Med. 2007 Feb-Mar;69(2):191-9
pubmed: 17289823
Alzheimer Dis Assoc Disord. 2017 Oct-Dec;31(4):287-294
pubmed: 28891819
Burns. 2018 Nov;44(7):1709-1720
pubmed: 29287729
Lancet Neurol. 2018 Mar;17(3):268-278
pubmed: 29452686
Clin Geriatr Med. 2001 Aug;17(3):457-78, vi
pubmed: 11459715
Pharmacy (Basel). 2017 Jun 01;5(2):
pubmed: 28970442
Rev Neurol (Paris). 2012 Jan;168(1):28-32
pubmed: 22153704
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759